Motilal Oswal Recommends To ‘Buy’ This Pharma Stock For +30% Upside, While Equity Market Is Down For Omicron

The equity market is down as the investors are concerned about the new variant of the Covid virus named Omicron, which was first reported in South Africa. However, the pharma stocks are outperforming other company stocks, as happened during the first